Citius Pharmaceuticals, Inc. (CTXR)

NASDAQ: CTXR · IEX Real-Time Price · USD

0.512

-0.031 (-5.74%)

At close: Jul 2, 2024, 4:00 PM

0.519

+0.007 (1.35%)

After-hours: Jul 2, 2024, 7:53 PM EDT

Citius Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	Current	2023	2022	2021	2020	2019	2018 - 2014
Market Capitalization	93	109	177	296	58	17	Upgrade
Market Cap Growth	-16.58%	-38.51%	-40.33%	413.63%	245.02%	-39.63%	Upgrade
Enterprise Value	80	83	136	227	45	9	Upgrade
PE Ratio	-	-3.23	-5.26	-12.09	-3.29	-1.07	Upgrade
PB Ratio	1.17	1.20	1.72	2.24	1.71	0.62	Upgrade
P/FCF Ratio	-4.71	-3.74	-6.23	-12.22	-3.41	-1.34	Upgrade
P/OCF Ratio	-4.71	-3.74	-6.23	-12.22	-3.41	-1.34	Upgrade
EV/EBITDA Ratio	-3.69	-2.60	-4.13	-9.93	-2.60	-0.58	Upgrade
EV/EBIT Ratio	-3.66	-2.59	-4.11	-9.85	-2.57	-0.58	Upgrade
EV/FCF Ratio	-4.31	-2.85	-4.79	-9.36	-2.67	-0.72	Upgrade
Debt / Equity Ratio	0.00	0.01	0.01	0.01	0.04	0.01	Upgrade
Debt / EBITDA Ratio	-0.01	-0.02	-0.02	-0.04	-0.08	-0.01	Upgrade
Debt / FCF Ratio	-0.01	-0.02	-0.02	-0.04	-0.08	-0.01	Upgrade
Quick Ratio	3.02	4.59	9.22	17.61	3.40	1.73	Upgrade
Current Ratio	5.17	5.95	9.84	18.29	3.41	1.72	Upgrade
Interest Coverage	-	-	-	-2125.99	-1118.64	-945.43	Upgrade
Return on Equity (ROE)	-42.40%	-35.50%	-29.60%	-23.40%	-66.70%	-66.40%	Upgrade
Return on Assets (ROA)	-37.20%	-31.30%	-26.90%	-21.40%	-52.50%	-54.30%	Upgrade
Return on Capital (ROIC)	-49.04%	-40.23%	-32.19%	-17.69%	-50.57%	-57.08%	Upgrade
Earnings Yield	-40.37%	-30.99%	-19.03%	-8.27%	-30.42%	-93.06%	Upgrade
FCF Yield	-32.75%	-26.73%	-16.04%	-8.19%	-29.35%	-74.38%	Upgrade
Buyback Yield / Dilution	-8.77%	-3.57%	-34.52%	-177.28%	-94.25%	-87.87%	Upgrade
Total Shareholder Return	-8.77%	-3.57%	-34.52%	-177.28%	-94.25%	-87.87%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).